Thus, A2AR-PAM optochemistry could provide certain patients with effective and safe treatment for various diseases, such as treatment-resistant insomnia, also known as chronic insomnia, for which most available therapeutic options are unsatisfactory, leaving patients desperate for alternative therapies. Here, ADORA2A is linked to insomnia measurement.